Cargando…
The Complex Association between COPD and COVID-19
Chronic obstructive pulmonary disease (COPD) is significant cause of morbidity and mortality worldwide. There is mounting evidence suggesting that COPD patients are at increased risk of severe COVID-19 outcomes; however, it remains unclear whether they are more susceptible to acquiring SARS-CoV-2 in...
Autores principales: | Awatade, Nikhil T., Wark, Peter A. B., Chan, Andrew S. L., Mamun, SM Abdullah Al, Mohd Esa, Nurul Yaqeen, Matsunaga, Kazuto, Rhee, Chin Kook, Hansbro, Philip M., Sohal, Sukhwinder Singh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253799/ https://www.ncbi.nlm.nih.gov/pubmed/37297985 http://dx.doi.org/10.3390/jcm12113791 |
Ejemplares similares
-
Fluticasone propionate and increased risk of pneumonia in COPD: is it PAFR-dependent?
por: Sohal, Sukhwinder Singh
Publicado: (2017) -
Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights
por: Wark, Peter A.B., et al.
Publicado: (2021) -
Epithelial–mesenchymal transition is driven by transcriptional and post transcriptional modulations in COPD: implications for disease progression and new therapeutics
por: Eapen, Mathew Suji, et al.
Publicado: (2019) -
Therapeutic Modalities for Asthma, COPD, and Pathogenesis of COVID-19: Insights from the Special Issue
por: Sohal, Sukhwinder Singh
Publicado: (2022) -
Endothelial to mesenchymal transition (EndMT): an active process in Chronic Obstructive Pulmonary Disease (COPD)?
por: Sohal, Sukhwinder Singh
Publicado: (2016)